Prognostic Factors in the Era of Targeted Therapies in CLL.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 78, doi. 10.1007/s11899-018-0439-9
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2018 AND VI 13 AND IP 2
Results: 8
1
2
Frontline Therapy of CLL: Evolving Treatment Paradigm.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 69, doi. 10.1007/s11899-018-0438-x
- By:
- Publication type:
- Article
3
Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 125, doi. 10.1007/s11899-018-0444-z
- By:
- Publication type:
- Article
4
Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 114, doi. 10.1007/s11899-018-0443-0
- By:
- Publication type:
- Article
5
Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 100, doi. 10.1007/s11899-018-0442-1
- By:
- Publication type:
- Article
6
Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on Delirium.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 109, doi. 10.1007/s11899-018-0441-2
- By:
- Publication type:
- Article
7
Novel Therapies for Older Adults With Acute Lymphoblastic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 91, doi. 10.1007/s11899-018-0440-3
- By:
- Publication type:
- Article
8
Update on the Treatment of Anaplastic Large Cell Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 2, p. 135, doi. 10.1007/s11899-018-0436-z
- By:
- Publication type:
- Article